Abstract Purpose of Review It is clear from epidemiological studies that patients at high and
very-high risk of atherosclerotic cardiovascular diseases (ASCVD) risk do not reach lipid …

Polypill is a multi-drug formulation in a single pill intended to simplify the drug regimen and
reduce medication-induced adverse effects. The most common multidrug combinations in a …

Although the cardiovascular (CV) polypill concept is not new and several guidelines state
that a CV polypill should be considered an integral part of a comprehensive CV disease …

Background: Uncontrolled blood pressure is a major risk factor for cardiovascular diseases.
Fixed-dose combination (FDC) therapy offers a promising approach to addressing this …

Heart failure (HF) is emerging as a major public health problem both in high-and low-income
countries. The mortality and morbidity due to HF is substantially higher in low-middle income …

Cardiovascular diseases (CVD) are the leading cause of global mortality and the leading
cause of disability in the world. The leading modifiable risk factors for CVD-the level of …

Heart failure (HF) is emerging as a major public health problem both in high-and low-income
countries. The mortality and morbidity due to HF is substantially higher in low-middle income …

Editorial commentary: Polypills: Common garden variety or precision formulated for improving
cardiovascular outcomes: An ongoing challenge Editorial commentary: Polypills: Common …